Body Contouring Devices Market by Type (Invasive, Minimally & Non-Invasive), Functionality (Portable, Stationary), Application, End User, Distribution Channel - Global Forecast 2025-2032
Description
The Body Contouring Devices Market was valued at USD 2.09 billion in 2024 and is projected to grow to USD 2.34 billion in 2025, with a CAGR of 12.47%, reaching USD 5.37 billion by 2032.
Understanding the Dynamic Evolution and Emerging Opportunities in the Global Body Contouring Devices Market Amid Technological Consumer and Regulatory Shifts
The global body contouring devices sector has experienced a dynamic transformation over the past decade, propelled by technological innovation, shifting consumer preferences, and evolving regulatory landscapes. As medical professionals and aesthetic practitioners seek safer, more effective, and less invasive alternatives, manufacturers have responded with a diverse portfolio of solutions ranging from traditional liposuction platforms to cutting-edge cryolipolysis and radiofrequency systems. This convergence of clinical demand and engineering ingenuity has set the stage for a market environment characterized by rapid product introductions and growing adoption in both professional and at-home settings.
Moreover, the interplay between consumer awareness, digital marketing, and clinical outcomes has elevated patient expectations, driving suppliers to emphasize efficacy, safety, and user experience. Regulatory bodies around the world have concurrently refined their frameworks to ensure rigorous standards, influencing product development timelines and market entry strategies. Consequently, stakeholders must navigate a labyrinth of compliance requirements while leveraging emerging trends in personalization and data-driven care delivery.
In response to these dynamics, this executive summary distills the essential insights needed to understand the current state of the market, spotlight transformative shifts, examine regulatory impacts such as tariff changes, and highlight segmentation and regional patterns. By synthesizing these findings, readers will gain a comprehensive foundation for informed decision-making and strategic planning in the evolving landscape of body contouring devices.
Identifying Transformative Forces Driving Rapid Advancement Disruption and Integration in Body Contouring Technologies and Consumer Adoption Trends
Body contouring technologies have undergone a series of transformative shifts as novel modalities and cross-disciplinary integrations reshape the competitive terrain. Minimally invasive techniques such as cryolipolysis and ultrasound have gained traction, offering patients shorter recovery times and reduced risk profiles. Simultaneously, established invasive procedures continue to evolve through precision-engineered liposuction and abdominoplasty devices that enhance clinical outcomes. As a result, companies are investing heavily in research collaborations and strategic partnerships to harness synergies between surgical expertise and noninvasive innovation.
Furthermore, digitalization has introduced a new dimension of personalization and remote monitoring. Advances in artificial intelligence and imaging technology enable real-time feedback, tailored treatment protocols, and seamless integration with telehealth platforms. These developments are disrupting conventional channels of service delivery, prompting both practitioners and patients to embrace hybrid models that combine in-person procedures with virtual follow-up. Consequently, stakeholders who proactively adapt to these disruptive and integrative trends will be best positioned to capture emerging segments and optimize operational efficiencies.
Analyzing the Cumulative Impact of United States Tariffs in 2025 on Supply Chain Costs Market Accessibility and Competitiveness in Body Contouring Markets
The imposition of additional tariffs in 2025 on imports of key components and finished devices in the United States has generated a ripple effect across the body contouring ecosystem. Manufacturers reliant on cross-border supply chains face increased cost pressures that may translate into higher price points for end users. Providers are reevaluating procurement strategies, exploring alternative suppliers, and in certain cases, considering regional assembly or localized manufacturing to mitigate duty-related expenses.
In addition, the rising cost of imported equipment has prompted distributors and clinics to engage in more rigorous cost-benefit analyses before committing to new platform acquisitions. While some entities may absorb marginal increases to maintain competitive service offerings, others are likely to negotiate bulk purchase agreements or shift toward modular, upgradable systems that spread capital expenditure over time. Ultimately, these tariff-induced dynamics will resonate through pricing models, market accessibility, and the overall pace of adoption, underscoring the necessity for strategic supply chain optimization and resilient sourcing frameworks.
Uncovering Critical Segmentation Insights Revealing How Type Functionality Application End User and Distribution Channel Dimensions Shape Market Dynamics
An examination of market segmentation reveals a nuanced tapestry of demand drivers and growth trajectories. Based on type, traditional liposuction and excisional surgery devices continue to command established demand among surgical practitioners, whereas minimally and noninvasive solutions like cryolipolysis, laser treatments, radiofrequency, and ultrasound are capturing market share through outpatient clinics and aesthetic spas. Transitioning seamlessly, functionality segmentation demonstrates that stationary platforms dominate facility-based applications, while portable units are increasingly favored for point-of-care flexibility and home use scenarios.
Application-based insights indicate that abdomen reshaping-specifically targeting the belly and waist-remains the most prevalent procedure, but facial contouring for cheeks, chin, and jawline is experiencing accelerated uptake driven by social media influencers and personalized aesthetics. Meanwhile, lower body contouring of buttocks and thighs has surged in popularity alongside upper body treatments focused on arms and back toning. Finally, end user segmentation underscores the pivotal roles of cosmetic clinics and medical spas as primary service providers, though hospitals are enhancing their offerings with hybrid treatment suites, and home users are adopting handheld devices through online channels. Distribution channel patterns emphasize that offline sales still dominate high-value transactions, even as online platforms democratize access to consumer-grade solutions.
Highlighting Key Regional Insights Demonstrating Distinct Growth Drivers and Adoption Patterns in Americas Europe Middle East Africa and Asia Pacific Markets
Regional analysis demonstrates that the Americas continue to lead in technological adoption and procedure volume, fueled by strong reimbursement frameworks and high patient awareness of aesthetic services. Clinical establishments in North America are pioneering integrated treatment protocols that blend invasive and noninvasive techniques, while Latin America has emerged as a vibrant market for cost-sensitive, minimally invasive solutions.
In Europe, the Middle East, and Africa, regulatory harmonization efforts and medical tourism have catalyzed growth, particularly in specialized medical spas and boutique clinics. Patients increasingly travel across borders for premium treatments, creating a competitive environment that rewards innovative device offerings and service excellence. Conversely, the Asia-Pacific region is characterized by a rapidly expanding middle class, local manufacturing hubs, and culturally driven demand for both facial and body contouring procedures. Governments and policymakers in key markets are working to streamline approval processes, further accelerating adoption of advanced platforms.
Examining Leading Company Strategies Collaborations Innovations and Competitive Approaches Driving Advancement in the Body Contouring Devices Arena
Leading companies in the body contouring space are differentiating themselves through strategic acquisitions, co-development agreements, and targeted R&D investments. Several major players have expanded their portfolios by integrating digital imaging, AI-guided treatment planning, and device interoperability, thereby elevating the standard of care and reinforcing brand leadership. Moreover, collaborations with academic institutions and clinical research centers have yielded robust evidence on efficacy and safety, strengthening regulatory submissions and market credibility.
Innovation cycles are further accelerated by partnerships that stretch across disciplines, such as materials science firms providing novel energy delivery components or software developers contributing advanced analytics for outcome tracking. Together, these efforts underscore the competitive imperative to offer comprehensive solution suites that address clinician workflows, patient experience, and long-term performance. As a result, the market landscape is increasingly defined by a handful of agile, innovation-centric organizations that prioritize end-to-end integration and value-added services.
Providing Actionable Recommendations Empowering Industry Leaders to Capitalize on Innovations Streamline Operations and Strengthen Market Positioning in Body Contouring
To navigate the evolving body contouring environment, industry leaders should prioritize investment in modular, upgradeable platforms that accommodate emerging treatment modalities without necessitating full-system replacements. In parallel, cultivating strategic alliances with component suppliers and contract manufacturers can enhance supply chain resilience and buffer against sudden tariff fluctuations.
Additionally, developing comprehensive training programs and digital support tools for clinicians will accelerate technology adoption and differentiate offerings in crowded markets. Leveraging data analytics to capture real-world performance metrics enables evidence-based marketing and informs the iterative refinement of treatment protocols. Finally, companies must tailor regional go-to-market strategies by aligning product features with local regulatory standards, cultural preferences, and reimbursement models. By executing these recommendations, stakeholders can optimize growth trajectories, sustain competitive advantage, and deliver superior outcomes for both providers and patients.
Detailing Rigorous Research Methodology Incorporating Primary Expert Interviews Secondary Data Analysis and Validation Protocols Upholding Market Intelligence Integrity
This study employs a multi-phase research methodology designed to ensure data accuracy, reliability, and relevance. Primary research consisted of in-depth interviews with key opinion leaders, clinical specialists, device manufacturers, and distribution partners. These insights were complemented by secondary data collection from peer-reviewed journals, industry white papers, regulatory filings, and publicly available financial disclosures.
The collected information underwent rigorous validation protocols to reconcile discrepancies and triangulate findings. Quantitative analytics were supplemented with qualitative assessments to capture nuanced market dynamics, enabling a holistic view of technology adoption, regulatory compliance, and competitive positioning. Throughout the process, strict quality control measures were applied to maintain consistency, reduce bias, and uphold the integrity of the final analysis.
Synthesizing Comprehensive Insights Emphasizing the Strategic Implications for Stakeholders Navigating the Evolving Body Contouring Devices Ecosystem
In conclusion, the body contouring devices market stands at a pivotal juncture, shaped by technological breakthroughs, shifting patient expectations, and an increasingly complex regulatory environment. Stakeholders who adeptly integrate invasive and noninvasive solutions, optimize supply chains in response to tariff changes, and leverage data-driven insights will unlock significant competitive advantages.
Looking ahead, the convergence of personalized treatment planning, digital health integration, and global collaboration presents a compelling roadmap for sustainable growth. By embracing strategic agility and customer-centric innovation, industry participants can navigate market challenges and capitalize on the diverse opportunities inherent in this rapidly evolving landscape.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Type
Invasive
Excisional Surgery Devices
Traditional Liposuction Devices
Tummy Tucks (Abdominoplasty) Devices
Minimally & Non-Invasive
Cryolipolysis
Laser
Radiofrequency
Ultrasound
Functionality
Portable
Stationary
Application
Abdomen Reshaping
Belly
Waist
Facial Contouring
Cheeks
Chin
Jawline
Lower Body Contouring
Buttocks
Thigh
Upper Body Contouring
Arm
Back
End User
Cosmetic Clinics
Home Users
Hospitals
Medical Spas
Distribution Channel
Offline
Online
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Allergan Aesthetics by AbbVie Inc.
Alma Lasers Ltd.
Asclepion Laser Technologies GmbH
Bausch Health Companies Inc.
BioPhotas, Inc
BTL Industries, Inc.
Candela Corporation
Cartessa Aesthetics, LLC
Cutera, Inc.
Cynosure, LLC
DEKA M.E.L.A. srl by El.En. S.p.A.
ENDYMED
Erchonia Corporation
Fotona D.O.O.
Inmode Ltd
Lumenis Be Ltd.
Merz Pharma GmbH & Co. KGaA
MicroAire Surgical Instruments, LLC
Nouvag AG
Sciton Inc.
Sofwave Ltd.
Venus Concept
Zimmer MedizinSysteme GmbH
Please Note: PDF & Excel + Online Access - 1 Year
Understanding the Dynamic Evolution and Emerging Opportunities in the Global Body Contouring Devices Market Amid Technological Consumer and Regulatory Shifts
The global body contouring devices sector has experienced a dynamic transformation over the past decade, propelled by technological innovation, shifting consumer preferences, and evolving regulatory landscapes. As medical professionals and aesthetic practitioners seek safer, more effective, and less invasive alternatives, manufacturers have responded with a diverse portfolio of solutions ranging from traditional liposuction platforms to cutting-edge cryolipolysis and radiofrequency systems. This convergence of clinical demand and engineering ingenuity has set the stage for a market environment characterized by rapid product introductions and growing adoption in both professional and at-home settings.
Moreover, the interplay between consumer awareness, digital marketing, and clinical outcomes has elevated patient expectations, driving suppliers to emphasize efficacy, safety, and user experience. Regulatory bodies around the world have concurrently refined their frameworks to ensure rigorous standards, influencing product development timelines and market entry strategies. Consequently, stakeholders must navigate a labyrinth of compliance requirements while leveraging emerging trends in personalization and data-driven care delivery.
In response to these dynamics, this executive summary distills the essential insights needed to understand the current state of the market, spotlight transformative shifts, examine regulatory impacts such as tariff changes, and highlight segmentation and regional patterns. By synthesizing these findings, readers will gain a comprehensive foundation for informed decision-making and strategic planning in the evolving landscape of body contouring devices.
Identifying Transformative Forces Driving Rapid Advancement Disruption and Integration in Body Contouring Technologies and Consumer Adoption Trends
Body contouring technologies have undergone a series of transformative shifts as novel modalities and cross-disciplinary integrations reshape the competitive terrain. Minimally invasive techniques such as cryolipolysis and ultrasound have gained traction, offering patients shorter recovery times and reduced risk profiles. Simultaneously, established invasive procedures continue to evolve through precision-engineered liposuction and abdominoplasty devices that enhance clinical outcomes. As a result, companies are investing heavily in research collaborations and strategic partnerships to harness synergies between surgical expertise and noninvasive innovation.
Furthermore, digitalization has introduced a new dimension of personalization and remote monitoring. Advances in artificial intelligence and imaging technology enable real-time feedback, tailored treatment protocols, and seamless integration with telehealth platforms. These developments are disrupting conventional channels of service delivery, prompting both practitioners and patients to embrace hybrid models that combine in-person procedures with virtual follow-up. Consequently, stakeholders who proactively adapt to these disruptive and integrative trends will be best positioned to capture emerging segments and optimize operational efficiencies.
Analyzing the Cumulative Impact of United States Tariffs in 2025 on Supply Chain Costs Market Accessibility and Competitiveness in Body Contouring Markets
The imposition of additional tariffs in 2025 on imports of key components and finished devices in the United States has generated a ripple effect across the body contouring ecosystem. Manufacturers reliant on cross-border supply chains face increased cost pressures that may translate into higher price points for end users. Providers are reevaluating procurement strategies, exploring alternative suppliers, and in certain cases, considering regional assembly or localized manufacturing to mitigate duty-related expenses.
In addition, the rising cost of imported equipment has prompted distributors and clinics to engage in more rigorous cost-benefit analyses before committing to new platform acquisitions. While some entities may absorb marginal increases to maintain competitive service offerings, others are likely to negotiate bulk purchase agreements or shift toward modular, upgradable systems that spread capital expenditure over time. Ultimately, these tariff-induced dynamics will resonate through pricing models, market accessibility, and the overall pace of adoption, underscoring the necessity for strategic supply chain optimization and resilient sourcing frameworks.
Uncovering Critical Segmentation Insights Revealing How Type Functionality Application End User and Distribution Channel Dimensions Shape Market Dynamics
An examination of market segmentation reveals a nuanced tapestry of demand drivers and growth trajectories. Based on type, traditional liposuction and excisional surgery devices continue to command established demand among surgical practitioners, whereas minimally and noninvasive solutions like cryolipolysis, laser treatments, radiofrequency, and ultrasound are capturing market share through outpatient clinics and aesthetic spas. Transitioning seamlessly, functionality segmentation demonstrates that stationary platforms dominate facility-based applications, while portable units are increasingly favored for point-of-care flexibility and home use scenarios.
Application-based insights indicate that abdomen reshaping-specifically targeting the belly and waist-remains the most prevalent procedure, but facial contouring for cheeks, chin, and jawline is experiencing accelerated uptake driven by social media influencers and personalized aesthetics. Meanwhile, lower body contouring of buttocks and thighs has surged in popularity alongside upper body treatments focused on arms and back toning. Finally, end user segmentation underscores the pivotal roles of cosmetic clinics and medical spas as primary service providers, though hospitals are enhancing their offerings with hybrid treatment suites, and home users are adopting handheld devices through online channels. Distribution channel patterns emphasize that offline sales still dominate high-value transactions, even as online platforms democratize access to consumer-grade solutions.
Highlighting Key Regional Insights Demonstrating Distinct Growth Drivers and Adoption Patterns in Americas Europe Middle East Africa and Asia Pacific Markets
Regional analysis demonstrates that the Americas continue to lead in technological adoption and procedure volume, fueled by strong reimbursement frameworks and high patient awareness of aesthetic services. Clinical establishments in North America are pioneering integrated treatment protocols that blend invasive and noninvasive techniques, while Latin America has emerged as a vibrant market for cost-sensitive, minimally invasive solutions.
In Europe, the Middle East, and Africa, regulatory harmonization efforts and medical tourism have catalyzed growth, particularly in specialized medical spas and boutique clinics. Patients increasingly travel across borders for premium treatments, creating a competitive environment that rewards innovative device offerings and service excellence. Conversely, the Asia-Pacific region is characterized by a rapidly expanding middle class, local manufacturing hubs, and culturally driven demand for both facial and body contouring procedures. Governments and policymakers in key markets are working to streamline approval processes, further accelerating adoption of advanced platforms.
Examining Leading Company Strategies Collaborations Innovations and Competitive Approaches Driving Advancement in the Body Contouring Devices Arena
Leading companies in the body contouring space are differentiating themselves through strategic acquisitions, co-development agreements, and targeted R&D investments. Several major players have expanded their portfolios by integrating digital imaging, AI-guided treatment planning, and device interoperability, thereby elevating the standard of care and reinforcing brand leadership. Moreover, collaborations with academic institutions and clinical research centers have yielded robust evidence on efficacy and safety, strengthening regulatory submissions and market credibility.
Innovation cycles are further accelerated by partnerships that stretch across disciplines, such as materials science firms providing novel energy delivery components or software developers contributing advanced analytics for outcome tracking. Together, these efforts underscore the competitive imperative to offer comprehensive solution suites that address clinician workflows, patient experience, and long-term performance. As a result, the market landscape is increasingly defined by a handful of agile, innovation-centric organizations that prioritize end-to-end integration and value-added services.
Providing Actionable Recommendations Empowering Industry Leaders to Capitalize on Innovations Streamline Operations and Strengthen Market Positioning in Body Contouring
To navigate the evolving body contouring environment, industry leaders should prioritize investment in modular, upgradeable platforms that accommodate emerging treatment modalities without necessitating full-system replacements. In parallel, cultivating strategic alliances with component suppliers and contract manufacturers can enhance supply chain resilience and buffer against sudden tariff fluctuations.
Additionally, developing comprehensive training programs and digital support tools for clinicians will accelerate technology adoption and differentiate offerings in crowded markets. Leveraging data analytics to capture real-world performance metrics enables evidence-based marketing and informs the iterative refinement of treatment protocols. Finally, companies must tailor regional go-to-market strategies by aligning product features with local regulatory standards, cultural preferences, and reimbursement models. By executing these recommendations, stakeholders can optimize growth trajectories, sustain competitive advantage, and deliver superior outcomes for both providers and patients.
Detailing Rigorous Research Methodology Incorporating Primary Expert Interviews Secondary Data Analysis and Validation Protocols Upholding Market Intelligence Integrity
This study employs a multi-phase research methodology designed to ensure data accuracy, reliability, and relevance. Primary research consisted of in-depth interviews with key opinion leaders, clinical specialists, device manufacturers, and distribution partners. These insights were complemented by secondary data collection from peer-reviewed journals, industry white papers, regulatory filings, and publicly available financial disclosures.
The collected information underwent rigorous validation protocols to reconcile discrepancies and triangulate findings. Quantitative analytics were supplemented with qualitative assessments to capture nuanced market dynamics, enabling a holistic view of technology adoption, regulatory compliance, and competitive positioning. Throughout the process, strict quality control measures were applied to maintain consistency, reduce bias, and uphold the integrity of the final analysis.
Synthesizing Comprehensive Insights Emphasizing the Strategic Implications for Stakeholders Navigating the Evolving Body Contouring Devices Ecosystem
In conclusion, the body contouring devices market stands at a pivotal juncture, shaped by technological breakthroughs, shifting patient expectations, and an increasingly complex regulatory environment. Stakeholders who adeptly integrate invasive and noninvasive solutions, optimize supply chains in response to tariff changes, and leverage data-driven insights will unlock significant competitive advantages.
Looking ahead, the convergence of personalized treatment planning, digital health integration, and global collaboration presents a compelling roadmap for sustainable growth. By embracing strategic agility and customer-centric innovation, industry participants can navigate market challenges and capitalize on the diverse opportunities inherent in this rapidly evolving landscape.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Type
Invasive
Excisional Surgery Devices
Traditional Liposuction Devices
Tummy Tucks (Abdominoplasty) Devices
Minimally & Non-Invasive
Cryolipolysis
Laser
Radiofrequency
Ultrasound
Functionality
Portable
Stationary
Application
Abdomen Reshaping
Belly
Waist
Facial Contouring
Cheeks
Chin
Jawline
Lower Body Contouring
Buttocks
Thigh
Upper Body Contouring
Arm
Back
End User
Cosmetic Clinics
Home Users
Hospitals
Medical Spas
Distribution Channel
Offline
Online
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Allergan Aesthetics by AbbVie Inc.
Alma Lasers Ltd.
Asclepion Laser Technologies GmbH
Bausch Health Companies Inc.
BioPhotas, Inc
BTL Industries, Inc.
Candela Corporation
Cartessa Aesthetics, LLC
Cutera, Inc.
Cynosure, LLC
DEKA M.E.L.A. srl by El.En. S.p.A.
ENDYMED
Erchonia Corporation
Fotona D.O.O.
Inmode Ltd
Lumenis Be Ltd.
Merz Pharma GmbH & Co. KGaA
MicroAire Surgical Instruments, LLC
Nouvag AG
Sciton Inc.
Sofwave Ltd.
Venus Concept
Zimmer MedizinSysteme GmbH
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
185 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of artificial intelligence imaging guidance in noninvasive body contouring protocols
- 5.2. Rapid emergence of portable home-use fat reduction devices with multi-wavelength laser technology
- 5.3. Growing adoption of combined radiofrequency and ultrasound modalities for targeted adipose tissue disruption
- 5.4. Advancements in cryolipolysis device design enabling faster treatment cycles and enhanced patient comfort
- 5.5. Increasing investment in personalized 3D simulation software for tailored body contouring treatment planning
- 5.6. Expansion of minimally invasive body contouring in emerging Asian and Latin American markets driven by lifestyle trends
- 5.7. Regulatory approvals accelerating launch of next generation high-intensity focused electromagnetic body sculpting systems
- 5.8. Integration of telehealth platforms for remote monitoring and follow-up in body contouring procedures
- 5.9. Rising interest in adipose tissue metabolic modulation therapies complementing traditional fat reduction devices
- 5.10. Focus on sustainable and recyclable materials in disposable components of body shaping applicators
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Body Contouring Devices Market, by Type
- 8.1. Invasive
- 8.1.1. Excisional Surgery Devices
- 8.1.2. Traditional Liposuction Devices
- 8.1.3. Tummy Tucks (Abdominoplasty) Devices
- 8.2. Minimally & Non-Invasive
- 8.2.1. Cryolipolysis
- 8.2.2. Laser
- 8.2.3. Radiofrequency
- 8.2.4. Ultrasound
- 9. Body Contouring Devices Market, by Functionality
- 9.1. Portable
- 9.2. Stationary
- 10. Body Contouring Devices Market, by Application
- 10.1. Abdomen Reshaping
- 10.1.1. Belly
- 10.1.2. Waist
- 10.2. Facial Contouring
- 10.2.1. Cheeks
- 10.2.2. Chin
- 10.2.3. Jawline
- 10.3. Lower Body Contouring
- 10.3.1. Buttocks
- 10.3.2. Thigh
- 10.4. Upper Body Contouring
- 10.4.1. Arm
- 10.4.2. Back
- 11. Body Contouring Devices Market, by End User
- 11.1. Cosmetic Clinics
- 11.2. Home Users
- 11.3. Hospitals
- 11.4. Medical Spas
- 12. Body Contouring Devices Market, by Distribution Channel
- 12.1. Offline
- 12.2. Online
- 13. Body Contouring Devices Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Body Contouring Devices Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Body Contouring Devices Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. Allergan Aesthetics by AbbVie Inc.
- 16.3.2. Alma Lasers Ltd.
- 16.3.3. Asclepion Laser Technologies GmbH
- 16.3.4. Bausch Health Companies Inc.
- 16.3.5. BioPhotas, Inc
- 16.3.6. BTL Industries, Inc.
- 16.3.7. Candela Corporation
- 16.3.8. Cartessa Aesthetics, LLC
- 16.3.9. Cutera, Inc.
- 16.3.10. Cynosure, LLC
- 16.3.11. DEKA M.E.L.A. srl by El.En. S.p.A.
- 16.3.12. ENDYMED
- 16.3.13. Erchonia Corporation
- 16.3.14. Fotona D.O.O.
- 16.3.15. Inmode Ltd
- 16.3.16. Lumenis Be Ltd.
- 16.3.17. Merz Pharma GmbH & Co. KGaA
- 16.3.18. MicroAire Surgical Instruments, LLC
- 16.3.19. Nouvag AG
- 16.3.20. Sciton Inc.
- 16.3.21. Sofwave Ltd.
- 16.3.22. Venus Concept
- 16.3.23. Zimmer MedizinSysteme GmbH
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
